Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: A systematic literature review-Reference-Cited by-同舟云学术

Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: A systematic literature review

Published:2022-04-19 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Bencina Goran¹^ORCID,Fues Wahl Hanna²^ORCID,Tsoumani Eleana³,Salomonsson Stina⁴

Affiliation:

1. MSD, Center for Observational and Real-World Evidence (CORE), Madrid, Spain

2. Quantify Research AB, Stockholm, Sweden

3. MSD, Center for Observational and Real-World Evidence (CORE), Athens, Greece

4. MSD, Center for Observational and Real-World Evidence (CORE), Stockholm, Sweden

Funder

MSD

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2060017

Reference77 articles.

1. Understanding the burden of pneumococcal disease in adults

2. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management

3. Centers for Disease Control and Prevention (CDC). Pneumococcal Disease - Risk Factors; 2017. https://www.cdc.gov/pneumococcal/clinicians/risk-factors.html.

4. European Centre for Disease Prevention and Control (ECDC). Disease factsheet about pneumococcal disease; 2020. https://www.ecdc.europa.eu/en/pneumococcal-disease/facts.

5. Pneumococcal infection in adults: burden of disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature;Human Vaccines & Immunotherapeutics;2023-11-28

2. Evolution of Pneumococcal Vaccine Recommendations and Criteria for Decision Making in 5 Western European Countries and the United States;MDM Policy & Practice;2023-01